UroGen Pharma Ltd. Bonus & Incentive Agreements
14 Contracts & Agreements
- UroGen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on August 8, 2024)
- Form of Performance Stock Award Grant Notice and Performance Stock Award Agreement under the UroGen Pharma Ltd. Israeli Sub-Plan to 2017 Equity Incentive Plan (Filed With SEC on May 13, 2024)
- Amendment to Form of Performance-Based Restricted Stock Unit Grant Notice under the UroGen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on May 13, 2024)
- Amendment to Form of Restricted Stock Unit Grant Notice under the UroGen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on March 14, 2024)
- Performance-Based Restricted Stock Unit Grant Notice by and between the Registrant and Elizabeth Barrett, dated as of November 13, 2023 (Filed With SEC on November 14, 2023)
- Form of Performance-Based Restricted Stock Unit Grant Notice and Performance-Based Restricted Stock Unit Award Agreement under the Urogen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on November 14, 2023)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Urogen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on November 14, 2023)
- Form of Stock Option Grant Notice and Stock Option Agreement under the Urogen Pharma Ltd. 2017 Equity Incentive Plan (Filed With SEC on November 14, 2023)
- 2017 Equity Incentive Plan, as amended (Filed With SEC on November 14, 2023)
- 2017 Equity Incentive Plan, as amended (Filed With SEC on March 24, 2023)
- UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 13, 2022)
- UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 8, 2021)
- UroGen Pharma Ltd. 2017 Equity Incentive Plan, as amended (Filed With SEC on June 10, 2020)
- 2017 Equity Incentive Plan, as amended (Filed With SEC on February 28, 2019)
